Cargando…

The mutational landscape of MYCN, Lin28b and ALK(F1174L) driven murine neuroblastoma mimics human disease

Genetically engineered mouse models have proven to be essential tools for unraveling fundamental aspects of cancer biology and for testing novel therapeutic strategies. To optimally serve these goals, it is essential that the mouse model faithfully recapitulates the human disease. Recently, novel mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Wilde, Bram, Beckers, Anneleen, Lindner, Sven, Kristina, Althoff, De Preter, Katleen, Depuydt, Pauline, Mestdagh, Pieter, Sante, Tom, Lefever, Steve, Hertwig, Falk, Peng, Zhiyu, Shi, Le-Ming, Lee, Sangkyun, Vandermarliere, Elien, Martens, Lennart, Menten, Björn, Schramm, Alexander, Fischer, Matthias, Schulte, Johannes, Vandesompele, Jo, Speleman, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823580/ https://www.ncbi.nlm.nih.gov/pubmed/29492199 http://dx.doi.org/10.18632/oncotarget.23614

Ejemplares similares

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation
por: Beckers, Anneleen, et al.
Publicado: (2014)

Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
por: Kumps, Candy, et al.
Publicado: (2013)

External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data
por: Vermeulen, Joëlle, et al.
Publicado: (2009)

Measurable impact of RNA quality on gene expression results from quantitative PCR
por: Vermeulen, Joëlle, et al.
Publicado: (2011)

Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome
por: Claeys, Shana, et al.
Publicado: (2017)

Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions
por: De Preter, Katleen, et al.
Publicado: (2008)

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009)

Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons
por: De Preter, Katleen, et al.
Publicado: (2004)

Cancer Gene Prioritization for Targeted Resequencing Using FitSNP Scores
por: Fieuw, Annelies, et al.
Publicado: (2012)

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
por: De Wyn, Jolien, et al.
Publicado: (2021)

RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts
por: Vermeulen, Joëlle, et al.
Publicado: (2009)

Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
por: Zhai, Lei, et al.
Publicado: (2023)

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
por: Althoff, K, et al.
Publicado: (2015)

ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT
por: Debruyne, D N, et al.
Publicado: (2016)

MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016)

Oncogenic ALK(F1174L) drives tumorigenesis in cutaneous squamous cell carcinoma
por: Gualandi, Marco, et al.
Publicado: (2020)

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
por: Djos, Anna, et al.
Publicado: (2022)

MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2015)

ViVar: A Comprehensive Platform for the Analysis and Visualization of Structural Genomic Variation
por: Sante, Tom, et al.
Publicado: (2014)

MYCN and mutationally activated ALK synergise in neuroblastoma
Publicado: (2012)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Targeted Genomic Screen Reveals Focal Long Non-Coding RNA Copy Number Alterations in Cancer Cell Lines
por: Volders, Pieter-Jan, et al.
Publicado: (2018)

Meta-mining of copy number profiles of high-risk neuroblastoma tumors
por: Depuydt, Pauline, et al.
Publicado: (2018)

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
por: Ma, Li, et al.
Publicado: (2010)

Targeting tachykinin receptors in neuroblastoma
por: Henssen, Anton G., et al.
Publicado: (2016)

In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2018)

Publisher Correction: In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2019)

Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma
por: Liu, Tingting, et al.
Publicado: (2021)

miRBase Tracker: keeping track of microRNA annotation changes
por: Van Peer, Gert, et al.
Publicado: (2014)

RTPrimerDB: the portal for real-time PCR primers and probes
por: Lefever, Steve, et al.
Publicado: (2009)

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
por: Vandesompele, Jo, et al.
Publicado: (2002)

Author Correction: Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
por: Rombaut, Dries, et al.
Publicado: (2019)

Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
por: Rombaut, Dries, et al.
Publicado: (2019)

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015)

Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11
por: De Preter, Katleen, et al.
Publicado: (2005)

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
por: Borenäs, Marcus, et al.
Publicado: (2021)

MYCN-mediated murine cancer models
por: Althoff, Kristina, et al.
Publicado: (2017)

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
por: Decaesteker, Bieke, et al.
Publicado: (2018)

Zipper plot: visualizing transcriptional activity of genomic regions
por: Avila Cobos, Francisco, et al.
Publicado: (2017)

Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells
por: Montavon, Gisèle, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6qn052fd243gg7v3ubdb2a9gih